MacuSight
Sirolimus-based product as a next-generation therapeutic for the treatment/prevention of wet AMD and the treatment of diabetic macular edema.
Get a Demo and See the Full Profile
Get a demo today to see profiles of MacuSight plus 5904 other startups.
